Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $18.24B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.70B | 9.3% |
| Business Acquisitions | $1.18B | 6.5% |
| Other Investing | $9.18B | 50.4% |
| Stock Repurchases | $451.0M | 2.5% |
| Other Financing | $5.11B | 28.0% |
| Other | $605.0M | 3.3% |
| Net Cash Flow | $0 | 0.0% |